Skip to content

Comparative Study of Hypertonic Saline and Budesonide Solution versus Fluticasone Spray in Post-Sinus Surgery Care of Patients with Nasal Polyposis

Comparative Evaluation of the Therapeutic Effects of Hypertonic Saline Solution with Budesonide versus Fluticasone Nasal Spray in Postoperative Care Following Functional Endoscopic Sinus Surgery in Patients with Chronic Rhinosinusitis with Nasal Polypsc

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
IRCT
Registry ID
IRCT20251207068236N1
Enrollment
80
Registered
2026-01-09
Start date
2024-11-05
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic rhinosinusitis with nasal polyposis.

Interventions

Intervention 1: Intervention group: Received hypertonic saline solution combined with budesonide for nasal irrigation. Intervention 2: Intervention group: Received intranasal fluticasone spray.

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 18 years Diagnosis of chronic rhinosinusitis with nasal polyposis based on the criteria of the Rhinology Society Successful completion of Functional Endoscopic Sinus Surgery (FESS) Written informed consent to participate in the study No use of systemic corticosteroid medications within the past 4 weeks

Exclusion criteria

Exclusion criteria: History of allergy or intolerance to the study medications (budesonide or fluticasone Presence of severe underlying diseases such as immunodeficiency, uncontrolled diabetes, or advanced cardiac disease Lack of cooperation in completing questionnaires or attending follow-up visits Occurrence of severe postoperative complications requiring treatment outside the study protocol

Design outcomes

Primary

MeasureTime frame
Severity score of sinusitis in the SNOT-22 questionnaire. Timepoint: Before surgery and at the fourth week after surgery. Method of measurement: SNOT-22 questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Golmohammadi

Tabriz University of Medical Sciences

draligolmohammadi@gmail.com+98 914 855 3874

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026